Abstract
In nearly all cases of biological activity of sulfated GAGs, the sulfate group(s) are critical for interacting with target proteins. A growing paradigm is that appropriate small, sulfated, nonsaccharide GAG mimetics can be designed to either mimic or interfere with the biological functions of natural GAG sequences resulting in the discovery of either antagonist or agonist agents. A number of times these sulfated NSGMs can be computationally designed based on the parent GAG–protein interaction. The small sulfated NSGMs may possess considerable aromatic character so as to engineer hydrophobic, hydrogen-bonding, Coulombic or cation–pi forces in their interactions with target protein(s) resulting in higher specificity of action relative to parent GAGs. The sulfated NSGMs can be easily synthesized in one step from appropriate natural polyphenols through chemical sulfation under microwave-based conditions. We describe step-by-step procedures to perform microwave-based sulfation of several small polyphenol scaffolds so as to prepare homogenous NSGMs containing one to more than 10 sulfate groups per molecule in high yields.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gandhi NS, Mancera RL (2008) The structure of glycosaminoglycans and their interactions with proteins. Chem Biol Drug Des 72:455–482
Silbert JE, Sugumaran G (2002) Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life 54:177–186
Kreuger J, Kjellén L (2012) Heparan sulfate biosynthesis. Regulation and variability. J Histochem Cytochem 60:898–907
Khan S, Fung KW, Rodriguez E, Patel R, Gor J, Mulloy B, Perkins SJ (2013) The solution structure of heparan sulfate differs from that of heparin, Implications for function. J Biol Chem 288:27737–27751
Khan S, Gor J, Mulloy B, Perkins SJ (2010) Semi-rigid solution structures of heparin by constrained X-ray scattering modeling: new insight into heparin-protein complexes. J Mol Biol 395:504–521, Erratum in (2013) J Mol Biol 425:1847
Gallagher JT (2012) Heparan sulphate: a heparin in miniature. Handb Exp Pharmacol 207:347–360
Desai UR (2013) The promise of sulfated synthetic small molecules as modulators of glycosaminoglycan function. Future Med Chem 5:1363–1366
Whitelock JM, Iozzo RV (2005) Heparan sulfate: a complex polymer charged with biological activity. Chem Rev 105:2745–2764
Al-Horani RA, Desai UR (2010) Chemical sulfation of small molecules – advances and challenges. Tetrahedron 66:2907–2918
Desai UR (2004) New antithrombin-based anticoagulants. Med Res Rev 24:151–181
Olson ST, Björk I, Bock SC (2002) Identification of critical molecular interactions mediating heparin activation of antithrombin: implications for the design of improved heparin anticoagulants. Trends Cardiovasc Med 12:198–205
Petitou M, van Boeckel CA (2004) A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next? Angew Chem Int Ed 43:3118–3133
Shukla D, Liu J, Blaiklock P, Shworak NW, Bai X, Esko JD, Cohen GH, Eisenberg RJ, Rosenberg RD, Spear PG (1999) A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99:13–22
Copeland R, Balasubramaniam A, Tiwari V, Zhang F, Bridges A, Linhardt RJ, Shukla D, Liu J (2008) Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry 47:774–5783
Raghuraman A, Mosier PD, Desai UR (2010) Understanding dermatan sulfate-heparin cofactor II interaction through virtual library screening. ACS Med Chem Lett 1:281–285
Raghuraman A, Mosier PD, Desai UR (2006) Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s). J Med Chem 49:3553–3562
Pichert A, Samsonov SA, Theisgen S, Thomas L, Baumann L, Schiller J, Beck-Sickinger AG, Huster D, Pisabarro MT (2012) Characterization of the interaction of interleukin-8 with hyaluronan, chondroitin sulfate, dermatan sulfate and their sulfated derivatives by spectroscopy and molecular modeling. Glycobiology 22:134–145
Bitomsky W, Wade RC (1999) Docking of glycosaminoglycans to heparin-binding proteins: validation for aFGF, bFGF, and antithrombin and application to IL-8. J Am Chem Soc 121:3004–3013
Grootenhuis PDJ, van Boeckel CAA (1991) Constructing a molecular model of the interaction between antithrombin III and a potent heparin analog. J Am Chem Soc 113:2743–2747
Sears P, Wong CH (1998) Enzyme action in glycoprotein synthesis. Cell Mol Life Sci 54:223–252
Sears P, Wong CH (2001) Toward automated synthesis of oligosaccharides and glycoproteins. Science 291:2344–2350
Seeberger PH, Haase WC (2000) Solid-phase oligosaccharide synthesis and combinatorial carbohydrate libraries. Chem Rev 100:4349–4393
Heidlas JE, Williams KW, Whitesides GM (1992) Nucleoside phosphate sugars: syntheses on practical scales for use as reagents in enzymatic preparation of oligosaccharides and glycoconjugates. Acc Chem Res 25:307–314
Karst NA, Linhardt RJ (2003) Recent chemical and enzymatic approaches to the synthesis of glycosaminoglycan oligosaccharides. Curr Med Chem 10:1993–2031
Borgia JA, Malkar NB, Abbasi HU, Fields GB (2001) Difficulties encountered during glycopeptide syntheses. J Biomol Tech 12:44–68
Hu YP, Lin SY, Huang CY, Zulueta MM, Liu JY, Chang W, Hung SC (2011) Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host-cell interaction. Nat Chem 3:557–563
Sheng GJ, Oh YI, Chang S-K, Hsieh-Wilson LC (2013) Tunable heparan sulfate mimetics for modulating chemokine activity. J Am Chem Soc 135:10898–10901
de Paz JL, Seeberger PH (2008) Deciphering the glycosaminoglycan code with the help of microarrays. Mol Biosyst 4:707–711
Yin J, Seeberger PH (2010) Applications of heparin and heparan sulfate microarrays. Methods Enzymol 478:197–218
Petitou M, Nancy-Portebois V, Dubreucq G, Motte V, Meuleman D, de Kort M, van Boeckel CA, Vogel GM, Wisse JA (2009) From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile. Thromb Haemostas 102:804–810
Saxena K, Schieborr U, Anderka O, Duchardt-Ferner E, Elshorst B, Gande SL, Janzon J, Kudlinzki D, Sreeramulu S, Dreyer MK, Wendt KU, Herbert C, Duchaussoy P, Bianciotto M, Driguez PA, Lassalle G, Savi P, Mohammadi M, Bono F, Schwalbe H (2010) Influence of heparin mimetics on assembly of the FGF · FGFR4 signaling complex. J Biol Chem 285:26628–26640
Sarrazin S, Bonnaffé D, Lubineau A, Lortat-Jacob H (2005) Heparan sulfate mimicry: a synthetic glycoconjugate that recognizes the heparin binding domain of interferon-gamma inhibits the cytokine activity. J Biol Chem 280:37558–37564
Lubineau A, Lortat-Jacob H, Gavard O, Sarrazin S, Bonnaffé D (2004) Synthesis of tailor-made glycoconjugate mimetics of heparan sulfate that bind IFN-γ in the nanomolar range. Chem Eur J 10:4265–4282
Ferro V, Dredge K, Liu L, Hammond E, Bytheway I, Li C, Johnstone K, Karoli T, Davis K, Copeman E, Gautam A (2007) PI-88 and novel heparan sulfate mimetics inhibit angiogenesis. Semin Thromb Hemostas 33:557–568
Nimjee SM, Oney S, Volovyk Z, Bompiani KM, Long SB, Hoffman M, Sullenger BA (2009) Synergistic effect of aptamers that inhibit exosites 1 and 2 on thrombin. RNA 15:2105–2111
Freeman C, Liu L, Banwell MG, Brown KJ, Bezos A, Ferro V, Parish CR (2005) Use of sulfated linked cyclitols as heparin sulfate mimetics to probe the heparin/heparan sulfate binding specificity of proteins. J Biol Chem 280:8842–8849
Türk H, Haag R, Alban S (2004) Dendritic polyglycerol sulfates as new heparin analogues and potent inhibitors of the complement system. Bioconjug Chem 15:162–167
Ferro V, Liu L, Johnstone KD, Wimmer N, Karoli T, Handley P, Rowley J, Dredge K, Li CP, Hammond E, Davis K, Sarimaa L, Harenberg J, Bytheway I (2012) Discovery of PG545: a highly potent and simultaneous inhibitor of angiogenesis, tumor growth, and metastasis. J Med Chem 55:3804–3813
Gunnarsson GT, Desai UR (2002) Designing small, nonsugar activators of antithrombin using hydropathic interaction analyses. J Med Chem 45:1233–1243
Gunnarsson GT, Desai UR (2002) Interaction of designed sulfated flavanoids with antithrombin: lessons on the design of organic activators. J Med Chem 45:4460–4470
Raghuraman A, Liang A, Krishnasamy C, Lauck T, Gunnarsson GT, Desai UR (2009) On designing non-saccharide, allosteric activators of antithrombin. Eur J Med Chem 44:2626–2631
Al-Horani RA, Liang A, Desai UR (2011) Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa. J Med Chem 54:6125–6138
Abdel Aziz MH, Sidhu PS, Liang A, Kim JY, Mosier PD, Zhou Q, Farrell DH, Desai UR (2012) Designing allosteric regulators of thrombin. Monosulfated benzofuran dimers selectively interact with Arg173 of exosite 2 to induce inhibition. J Med Chem 55:6888–6897
Sidhu PS, Abdel Aziz MH, Sarkar A, Mehta AY, Zhou Q, Desai UR (2013) Designing allosteric regulators of thrombin. Exosite 2 features multiple sub-sites that can be targeted by sulfated small molecules for inducing inhibition. J Med Chem 56:5059–5070
Al-Horani RA, Ponnusamy P, Mehta AY, Gailani D, Desai UR (2013) Sulfated Pentagalloylglucoside is a potent, allosteric, and selective inhibitor of factor XIa. J Med Chem 56:867–878
Dusza JP, Joseph JP, Bernstein S (1985) The preparation of estradiol-17 beta sulfates with triethylamine-sulfur trioxide. Steroids 45:303–315
Kitagawa K, Aida C, Fujiwara H, Yagami T, Futaki S, Kogire M, Ida J, Inoue K (2001) Facile solid-phase synthesis of sulfated tyrosine-containing peptides: total synthesis of human big gastrin-II and cholecystokinin (CCK)-39. J Org Chem 66:1–10
Lee JC, Lu XA, Kulkarni SS, Wen YS, Hung SC (2004) Synthesis of heparin oligosaccharides. J Am Chem Soc 126:476–477
Tully SE, Mabon R, Gama CI, Tsai SM, Liu X, Hsieh-Wilson LC (2004) A chondroitin sulfate small molecule that stimulates neuronal growth. J Am Chem Soc 126:7736–7737
Young T, Kiessling LL (2002) A strategy for the synthesis of sulfated peptides. Angew Chem Int Ed Engl 41:3449–3451
Krylov VB, Ustyuzhanina NE, Grachev AA, Nifantiev NE (2008) Efficient acid-promoted per-O-sulfation of organic polyols. Tetrahedron Lett 49:5877–5879
Raghuraman A, Riaz M, Hindle M, Desai UR (2007) Rapid and efficient microwave-assisted synthesis of highly sulfated organic scaffolds. Tetrahedron Lett 48:6754–6758
Monien BH, Henry BL, Raghuraman A, Hindle M, Desai UR (2006) Novel chemo-enzymatic oligomers of cinnamic acids as direct and indirect inhibitors of coagulation proteinases. Bioorg Med Chem 14:7988–7998
Henry BL, Monien BH, Bock PE, Desai UR (2007) A novel allosteric pathway of thrombin inhibition: exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acids. J Biol Chem 282:31891–31899
Henry BL, Abdel Aziz M, Zhou Q, Desai UR (2010) Sulfated, low-molecular-weight lignins are potent inhibitors of plasmin, in addition to thrombin and factor Xa: novel opportunity for controlling complex pathologies. Thromb Haemost 103:507–515
Saluja B, Thakkar JN, Li H, Desai UR, Sakagami M (2013) Novel low molecular weight lignins as potential anti-emphysema agents: in vitro triple inhibitory activity against elastase, oxidation and inflammation. Pulm Pharmacol Ther 26:296–304
Raghuraman A, Tiwari V, Zhao Q, Shukla D, Debnath AK, Desai UR (2007) Viral inhibition studies on sulfated lignin, a chemically modified biopolymer and a potential mimic of heparan sulfate. Biomacromolecules 8:1759–1763
Raman K, Karuturi R, Swarup VP, Desai UR, Kuberan B (2012) Discovery of novel sulfonated small molecules that inhibit vascular tube formation. Bioorg Med Chem Lett 22:4467–4470
Khanbabaee K, Lötzerich K (1997) Efficient total synthesis of the natural products 2,3,4,6-tetra-O-galloyl-D-glucopyranose, 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose and the unnatural 1,2,3,4,6-penta-O-galloyl-α-d-glucopyranose. Tetrahedron 53:10725–10732
Karuturi R, Al-Horani RA, Mehta SC, Gailani D, Desai UR (2013) Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site. J Med Chem 56:2415–2428
Liang A, Thakkar JN, Desai UR (2010) Study of physico-chemical properties of novel highly sulfated, aromatic, mimetics of heparin and heparan sulfate. J Pharm Sci 99:1207–1216
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Al-Horani, R.A., Karuturi, R., Verespy, S., Desai, U.R. (2015). Synthesis of Glycosaminoglycan Mimetics Through Sulfation of Polyphenols. In: Balagurunathan, K., Nakato, H., Desai, U. (eds) Glycosaminoglycans. Methods in Molecular Biology, vol 1229. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1714-3_7
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1714-3_7
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1713-6
Online ISBN: 978-1-4939-1714-3
eBook Packages: Springer Protocols